|
⚲
|
| Keyboard |
| Soleus Capital LLC
✚
|
|
|---|---|
| CIK # | 0001786724, 0001752361, 0001812276, 0001802630 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Krystal Biotech Inc | 0.3 | ||
| Celcuity Inc | 0.1 | ||
| Manhattan Pharmaceuticals Inc | 0.1 | ||
| Insulet Corp | 0.1 | ||
| Novocure Ltd | 0.1 | ||
| United Therapeutics Corp | 0.1 | ||
| Praxis Precision Medicines Inc | 0.1 | ||
| Aastrom Biosciences Inc | 0.1 | ||
| Alkermes PLC | 0.1 | ||
| Biosante Pharmaceuticals Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| D | [0001752361] | |
| 3 | [0001786724] | |
| 4 | [0001786724] | |
| SC 13G | [0001786724] | |
| 13F-HR | [0001802630] | |
| 3 | [0001802630] | |
| 4 | [0001802630] | |
| 3 | [0001812276] | |
| 4 | [0001812276] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Soleus Capital LLC | Dariohealth Corp | [2020-07-31] |
| Soleus Capital LLC | ESSA Pharma Inc | [2019-08-28] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Sell | 16,909 | $16.00 | 270,544 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Buy | 155,000 | $16.00 | 2,480,000 |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Conversion | 338,330 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Conversion | 104,608 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Common Stock
|
2020-05-05 | Option exercise | 31,382 | $8.63 | 270,827 |
|
Lyra Therapeutics Inc LYRA
Series B Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 11,666,666 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Common Stock Warrant · derivative
|
2020-05-05 | Option exercise | 31,382 | $0.00 | |
|
Lyra Therapeutics Inc LYRA
Series C Convertible Preferred Stock · derivative
|
2020-05-05 | Conversion | 3,607,224 | $0.00 |